dermatology
Medicines

The rise in checkpoint inhibitor skin reactions may have an upside


Dermatologists are being urged to be vigilant for cutaneous immune‐related adverse effects (irAEs) that are becoming more apparent with the increasing use of immune checkpoint inhibitors (ICIs) in cancers. According to a Commentary in the British Journal of Dermatology, the...

Dermatologists are being urged to be vigilant for cutaneous immune‐related adverse effects (irAEs) that are becoming more apparent with the...

Read more